IMV (Formerly Immunovaccine Inc.) to Present at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
142
IMV (Formerly Immunovaccine Inc.) to Present at the National Bank Financial Quebec Conference in Toronto

HALIFAX, Nova Scotia, May 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that IMV Chief Executive Officer Frederic Ors will present a corporate update at the National Bank Financial 8th Annual Quebec Conference .

Mr. Ors’ presentation will occur Wednesday, May 30, 2018 at 2:00 p.m. ET in the Museum Room in the Shangri-La Hotel in Toronto. A copy of the presentation will be available on IMV’s website: www.imv-inc.com

National Bank Financial Markets hosts a series of conferences and events each year to bring together business leaders, decision-makers and subject-matter experts to explore strategies, trends and opportunities.

About IMV IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the reprogramming of immune cells  in vivo,  which are aimed at generating powerful new synthetic therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a T cell activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently conducting three Phase 2 studies with Incyte and Merck assessing DPX-Survivac as a combination therapy in ovarian cancer and diffuse large B-cell lymphoma. Connect at  www.imv-inc.com .

IMV Forward-Looking Statements This press release contains forward-looking information under applicable securities law. All information that addresses activities or developments that we expect to occur in the future is forward-looking information. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. However, they should not be regarded as a representation that any of the plans will be achieved. Actual results may differ materially from those set forth in this press release due to risks affecting the Corporation, including access to capital, the successful completion of clinical trials and receipt of all regulatory approvals. IMV Inc. assumes no responsibility to update forward-looking statements in this press release except as required by law.

Contacts for Immunovaccine:

MEDIA  Mike Beyer, Sam Brown Inc. T: (312) 961-2502 E: mikebeyer@sambrown.com

INVESTOR RELATIONS Pierre Labbé, Chief Financial Officer T: (902) 492-1819 E: info@imv-inc.com

Patti Bank, Managing Director, Westwicke Partners O: (415) 513-1284 T: (415) 515-4572 E: patti.bank@westwicke.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICAC's Landmark Program Strengthens Africa's Anti-Corruption Efforts

Updated Category News Views 7

A Bold Step Towards Integrity Corruption has long been a thorn in the side of progress for many regions, and watching the Hong Kong International Academy Against Corruption (HKIAAC) step up to the plate in Africa feels like a much-needed move. I mean, when you've got the collective wisdom of folks who've been through the wringer on these issues, you'd be wise to pay heed....

Continue Reading
Hyliion Faces Legal Whirlwind After Stock Tumbles 19.3%

Updated Category News Views 11

Battered by Allegations: Hyliion in Legal Crosshairs Here's a hot mess Hyliion's found itself in. Amidst allegations of deception, the stock has dropped a hefty 19.3%. For anyone keeping tabs on this one, the legal eagles over at The Law Offices of Frank R. Cruz have swooped in, announcing a class action that's got all the trimmings of your classic securities mess. The...

Continue Reading
Ardelyx Investors Face Lawsuit Over Misleading Claims

Updated Category News Views 7

Investors Land in Hot Water with Ardelyx Alright, folks, here we go again. New York's courtroom dramas are in full swing with Ardelyx, Inc. at center stage, and not in a good way. The DJS Law Group has rallied the troops, reminding investors caught in the storm of a class action lawsuit. Specifically, it's all about alleged violations of the Securities Exchange Act of...

Continue Reading
Suunto Unleashes High-Tech Race 3S Watch with AI Coach

Updated Category News Views 6

The Latest in Performance Gear: Suunto's Race 3S Nobody wants their gear to be a limitation, especially out in the wild where every step counts. Enter Suunto's Race 3S—a watch that looks to change the game for those passionate about trail running. This gadget's packed with features meant for athletes who are serious about their tech, yet light enough to make you forget...

Continue Reading
Anita Eno: 2027's Top Trailblazing Businesswoman

Updated Category News Views 8

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

Continue Reading
Minesto Joins Sweden-Indonesia Partnership in Energy Shift

Updated Category News Views 4

Minesto's Big Splash in Indonesia's Energy Transition Here we go, folks. Minesto's taking the plunge into Indonesia's uncharted tidal waters under a Sweden-backed partnership. This Swedish underdog in ocean energy is ready to shake things up and ride the Indonesian currents, thanks to the Sweden-Indonesia Sustainability Partnership. Now, why should this matter to you, the...

Continue Reading
NVIDIA GTC Unveils Fleet's New AI Device Support

Updated Category News Views 3

Expanding the AI Frontier: Fleet Meets NVIDIA NVIDIA just pulled a major move at their GTC Berlin event, rolling out a comprehensive suite of device management for their AI hardware ecosystem through Fleet. Picture this: IT folks can now handle NVIDIA’s flagship AI gear alongside all those pesky other devices without losing their minds or sleep. From RTX PRO...

Continue Reading
PuroClean Shines in Franchise Rankings with Global Growth

Updated Category News Views 0

Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...

Continue Reading
Plaid Eyes Data Horizons; Acorns Embraces Gen Z

Updated Category News Views 4

Fintech's Next Frontier: Plaid's Vision You ever get the feeling some folks see further down the road than others? That's Plaid CTO Will Robinson, chatting up the NYSE folks at Money20/20. The man’s got his eyes on what he calls "making sense" of financial data—no small feat in our swamped digital world. Plaid ain't some penny stock operation, either. This is an $8...

Continue Reading
Hengrui Pharma at ESMO 2026: Innovations in Oncology

Updated Category News Views 7

Pushing Boundaries at ESMO 2026 If there's one place where the future of cancer treatment is being etched out, it's at forums like the ESMO Congress. This year, Hengrui Pharma is rolling in with 64 research findings hotter than a two-dollar pistol, all set to make waves in oncology. From breast to lung cancer, they're covering the lot and showcasing a blend of established...

Continue Reading

Top 5 Most Recently Viewed Articles

Amgen Declares Fourth Quarter Dividend Highlighting Innovation

Updated Category News Views 241

Amgen Declares Dividend for Fourth Quarter 2025 Amgen (NASDAQ: AMGN) recently announced an exciting development regarding its dividend strategy. The company’s Board of Directors has declared a dividend payment of $2.38 per share for the fourth quarter of 2025. This reflects Amgen’s ongoing commitment to delivering shareholder value while advancing its mission in...

Continue Reading
Longeveron’s New Patent Revolutionizes Female Sexual Health

Updated Category News Views 65

Breakthrough Patent by Longeveron for Female Sexual Dysfunction Longeveron Inc. (NASDAQ: LGVN), a prominent clinical stage biotechnology company, has recently announced an innovative patent that holds significant promise for women suffering from sexual dysfunction. The patent encompasses unique methods for administering therapeutic amounts of isolated allogeneic...

Continue Reading
Transforming Sexual Health: The Impact of Pelvic Tech Tools

Updated Category News Views 192

Transforming Sexual Health with Pelvic Tech Pelvic health, often overlooked in mainstream wellness discussions, is gaining much-needed attention through innovative tools known as pelvic tech. HoneyPlayBox is at the forefront of this exciting movement, offering a range of smart pelvic floor trainers designed to enhance sexual function, strengthen muscles, and boost overall...

Continue Reading
Discover How JCP&L Can Help Lower Your Electric Bill Today

Updated Category News Views 206

JCP&L's Commitment to Customer Support In difficult financial times, households often seek ways to manage their expenses, and Jersey Central Power and Light (JCP&L) is stepping up with valuable resources. JCP&L, part of FirstEnergy Corp. (NYSE: FE), understands the challenges faced by many customers. Their dedicated Energy Assistance Outreach Team (EAOT) stands ready to...

Continue Reading
Everstory Partners Revolutionizes Services with New Technology

Updated Category News Views 328

Everstory Partners Embraces Technology in End-of-Life Services In a remarkable transformation, Everstory Partners has shifted its operations from traditional methods to a tech-savvy approach in less than a year. This change has seen the company move from outdated paper maps and contracts to a sophisticated digital platform that enhances service delivery across its nearly...

Continue Reading